Phase I study of seliciclib (CYC202 or R-roscovitine) in combination with gemcitabine (gem)/cisplatin (cis) in patients with advanced non-small cell lung cancer (NSCLC).

Siegel-Lakhai, WS;Rodenstein, Daniel;Beijnen, JH;Gianella-Borradori, A;Talbot, DC;et.al.
(2005) 41st Annual Meeting of the American-Society-of-Clinical-Oncology — Location: Orlando (Fl) (13.May.2005)

Files

No attached file found for this publication.

Details

Authors
  • Siegel-Lakhai, WS
    Author
  • Rodenstein, DanielUCLouvain
    Author
  • Beijnen, JH
    Author
  • Gianella-Borradori, A
    Author
  • Talbot, DC
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Siegel-Lakhai, W., Rodenstein, D., Beijnen, J., Gianella-Borradori, A., Schellens, J., & Talbot, D. (2005). Phase I study of seliciclib (CYC202 or R-roscovitine) in combination with gemcitabine (gem)/cisplatin (cis) in patients with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology, 23(16), 150S-150S. https://hdl.handle.net/2078.5/140479 (Original work published 2005)